Our team members work and collaborate from all around the globe - with the goal of making longevity accessible for everyone. And we are continuously growing!

Read the latest coverage of the Longevity Investors Conference by MIT Technology Review: "Inside the billion-dollar meeting for the mega-rich who want to live forever."

We are very excited to announce that after the successful 2022 edition of the Longevity Investors Lunch during WEF we’re returning in January to Davos for the second edition. 

The invite-only event is co-hosted with Longevity Investors Conference, and will bring together investors interested in longevity-related research and provide latest insights into the longevity industry.

Maximon has two new joiners!

Simona Eicher, who joined Maximon as the "Lead Venture Builder", holds an MBA from University of Oxford, and a Master's in Management and Economics from the University of Zurich.

Bruno Marco Dufort, who joined Maximon as the "Junior Venture Builder", holds a PhD in biomedical engineering from ETH Zurich.

One of Maximon’s Founding Partners, Marc P. Bernegger participated in a Fireside Chat “From Internet in 1999 to Bitcoin in 2012 to longevity today” on November 3rd during Startup Nights in Winterthur, Switzerland. 

The Maximon, Avea and Biolytica teams went to another Retreat. These experiences give our teams a chance to bond as well as gain valuable insights and be creative. We are looking forward to the next one!

Our Founding Partner Dr. Tobias Reichmuth presented Maximon's Longevity Fund during SECA - Swiss Private Equity & Corporate Finance Association “Swiss VCs on Stage” Event at FIFA Museum in Zurich.